-
data infrastructure Design, develop, optimize, and maintain data architecture and pipelines (e.g., feeding medical data sources into data lake for ongoing projects) Partner with product manager and data
-
data infrastructure Design, develop, optimize, and maintain data architecture and pipelines (e.g., feeding medical data sources into data lake for ongoing projects) Partner with product manager and data
-
RESPONSIBILITIES Plan, execute and analyze in vivo pharmacology studies. Characterize new in vivo mouse models, including syngeneic genetically engineered and orthotopic mouse models to study biologic mechanisms and
-
to Clinical Study Protocols, Clinical Study Reports, Clinical Pharmacology plans for programs. Provides clinical pharmacology expertise to oncology project teams including planning, design, and oversight
-
customer segments and initiatives in an assigned territory. Antivirals and Diagnostics Field Medical Core Responsibilities Plan and execute medical strategy and engagement for appropriate assigned customers
-
phase development and commercial Internal partners, including the other units in ORU, and partner lines such as Medicinal Chemistry, Biomedicine Design and Drug Safety External collaborators including
-
the acquisition and divestiture of TMF contentwhile developing repeatable efficient process for TMF in integrations Lead design and execution of remediation projects and improvement projects Configure Study
-
disease states to optimize doses, dosage regimens and study designs throughout all phases (first-in-human through post-approval) of clinical drug development. With guidance, identify opportunities where
-
for scientific meetings and advisory boards Conduct literature reviews and prepare summaries to support clinical development programs Medical resource for design and interpretation of clinical and preclinical
-
Products (MDCP) Quality Operations team within the Pfizer Global Supply (PGS) organization. The incumbent provides quality assurance leadership/guidance of MDCPs related to design controls (21 CFR 820